The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy
Sophie R. de Mol van Otterloo(University Medical Center Utrecht), Helena M. Verkooijen(University Medical Center Utrecht), William A. Hall(Medical College of Wisconsin), Corinne Faivre‐Finn(National Health Service), Kevin Brown(Elekta (Sweden)), Kristina M. Orrling(Lygature), Arjun Sahgal(Sunnybrook Health Science Centre), Erwin L. A. Blezer(University Medical Center Utrecht), Robbert J.H.A. Tersteeg(University Medical Center Utrecht), Jeffrey G. Sarmiento(The University of Texas MD Anderson Cancer Center), Rob H.N. Tijssen(University Medical Center Utrecht), Martijn Intven(University Medical Center Utrecht), Claire McCann(Sunnybrook Health Science Centre), Bradley A. Erickson(Medical College of Wisconsin), Hafid Akhiat(Elekta (Sweden)), Baukelien van Triest(The Netherlands Cancer Institute), S. Hafeez(Royal Marsden NHS Foundation Trust), John P. Christodouleas(Elekta (Sweden)), Alison Tree(Institute of Cancer Research), Ananya Choudhury(University of Manchester), Robert Huddart(Institute of Cancer Research), Susan Lalondrelle(Royal Marsden NHS Foundation Trust), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), Emma Hall(The Royal Wolverhampton NHS Trust), Anna M. Kirby(Royal Marsden NHS Foundation Trust), Stella Mook(University Medical Center Utrecht), Kevin J. Harrington(Royal Marsden NHS Foundation Trust), Uwe Oelfke(Institute of Cancer Research), Bruce D. Minsky(Harvard University), Dave Eggert(Elekta (Sweden)), Joel Goldwein(Elekta (Sweden)), Uulke A. van der Heide(The Netherlands Cancer Institute), Marlies E. Nowee(The Netherlands Cancer Institute), Christopher J. Schultz(The University of Texas MD Anderson Cancer Center)
Cited by 150
Related Papers
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k